Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines

Author： Correia Marcelo LG   Haynes William G  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.3, 2005-08, pp. : 643-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel anti-obesity drugs

By Proietto J.   Fam B.C.   Ainslie D.A.   Thorburn A.W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1317-1326

Informa Healthcare

Access to resources Recommend Favorite

Fat Pills for Obesity's Ills: Novel Weight-Loss Drugs Emerging from the Pipeline

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 2, 2006-01 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

By Supuran Claudiu T   Fiore Anna Di   Simone Giuseppina De  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 383-392

Informa Healthcare

Access to resources Recommend Favorite

Novel obesity drugs, oncology biosimilars to impact markets

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 471-483

Bentham Science Publishers

Access to resources Recommend Favorite